Effects of Switching Efavirenz to Raltegravir on Vascular Function and Bone Markers in HIV-infected Patients
This study has been completed.
Sponsor:
Indiana University
Collaborator:
Merck
Information provided by (Responsible Party):
Samir Gupta, Indiana University
ClinicalTrials.gov Identifier:
NCT01270802
First received: January 4, 2011
Last updated: May 20, 2013
Last verified: May 2013
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been completed. |
|---|---|
| Study Completion Date: | April 2013 |
| Primary Completion Date: | October 2012 (Final data collection date for primary outcome measure) |